BETA
Invest Now
Start SIP in
BETA
Performance
- Low
- ₹1,780
- High
- ₹1,832
- 52 Week Low
- ₹1,119
- 52 Week High
- ₹2,215
- Open Price₹1,809
- Previous Close₹1,798
- Volume4,410
Investment Returns
- Over 1 Month + 3.62%
- Over 3 Month + 11.42%
- Over 6 Month -15.76%
- Over 1 Year + 52.62%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 117.3
- PEG Ratio
- -
- Market Cap Cr
- 1,810
- P/B Ratio
- 14.1
- Average True Range
- 67.86
- EPS
- 45.36
- Dividend Yield
- 0
- MACD Signal
- 9.66
- RSI
- 46.34
- MFI
- 44.73
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,793.25
-4.45
(-0.25%)

-
- Bearish Moving Average 14
-
- Bullish Moving Average 2
- 20 Day
- ₹1,827.33
- 50 Day
- ₹1,815.22
- 100 Day
- ₹1,797.73
- 200 Day
- ₹1,719.67
Resistance and Support
1801.72
- R3 1,875.33
- R2 1,853.62
- R1 1,823.43
- S1 1,771.53
- S2 1,749.82
- S3 1,719.63
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-15 | Audited Results | |
2025-03-27 | Others | To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
2025-02-05 | Issue of Bonus & Others | To consider other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
2024-11-06 | Quarterly Results | |
2024-10-19 | To consider Fund Raising |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,793 As on 12 June, 2025 | 21:36
The Market Cap of Beta Drugs is ₹1810.2 Cr As on 12 June, 2025 | 21:36
The P/E ratio of Beta Drugs is 117.3 As on 12 June, 2025 | 21:36
The PB ratio of Beta Drugs is 14.1 As on 12 June, 2025 | 21:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.